Maker of Chinese Vaccine Being Tested at Butantan Institute Says It Is Safe for Elderly

The elderly are a major target group for future Covid-19 immunization. Therefore, health authorities need to be satisfied that potential vaccines are safe and effective for this group.

RIO DE JANEIRO, BRAZIL - The Chinese Sinovac Biotech reported on Monday, September 7th, that the vaccine it is developing against Covid-19, in partnership with the Butantan Institute in São Paulo, proved to be safe for the elderly. However, the immunological responses triggered by the vaccine were . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?